Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
247 Assessment of sensitivity to a PD-1 check point inhibitor and cisplatin in bladder cancer patient-derived xenografts with various levels of PD-L1 expression in HuCD34NCG mice
Compose a Response to This Article
Other responses
No responses have been published for this article.